Özet:

Purpose: In retinal venous blocks, research on the effectiveness of grid laser photokoagulation, intravitreal triamsinolone acetonide and intravitreal bevacizumab injection. Methods: 78 of 78 patients with retinal venous obstructions between May 2008 and May 2010 in our clinic were reviewed backward. The diagnosis of retinal venous blocks was placed with fundus examination and with FFA withdrawal. Fifty eye grid laser photokoagulation, 8 eye 4 mg intravitreal triamsinolone acetonide, 20 eye 1.25 mg intravitreal bevacizumab was applied. Pre- and post-treatment has been assessed. Results: 31 of the patients (40%) were male and 47 (60%) female. The average age was 61 (44-78). Thirteen favourite central retinal venous inhibition (SRVT), 65 favourite retinal venous branch inhibition (VDT) were present. Thirty-four (44 percent) of patients with hypertension and 26 (33 percent) with diabetes mellitus were diagnosed. The average tracking time was 10.5 months (1-24 months). The initial best vision accuracy was an average of 1.12 LogMAR in the SRVT group, while the average was 1.08 LogMAR in the VDT group. The average best vision accuracy in the latest examination was 0.58 LogMAR in the SRVT group and 0.52 LogMAR in the VDT group. Three treatments also showed a statistically significant increase in vision accuracy (p=0.0). In the SRVT group, grid laser photokoagulation applicants were diagnosed with an average of 0.54 LogMAR, an average of 0.56 LogMAR in intravitreal triamsinolone acetonide injection, an average of 0.57 LogMAR injection in intravitreal bevacizumab injection. In the VDT group, the average of the grid laser photokoagulation applicants is 0. 52 LogMAR, intravitreal triamsinolone acetonide injections were provided with an average of 0.58 LogMAR injections, intravitreal bevacizumab injections with an average of 0.63 LogMAR injections. A statistically significant difference has been found between the Bevacizumab applicants and the grid laser photokoagulation applicants (p=0.0). There is no significant difference between triamsinolone acetonide and other treatments. Result: In the treatment of retinal venous inhibition, the application of grid laser photokoagulation, intravitreal triamsinolone acetonide and intravitreal bevacizumab is effective. Intravitreal bevacizumab injection has increased vision accuracy more than grid laser photokoagulation. There is no statistically significant difference between intravitreal bevacizumab and intravitreal triamsinolone injection. (JAREM 2012; 2: 6-9)

Anahtar Kelimeler: